MACARTNEY LAWSON

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 27% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
MACARTNEY LAWSON's trades of Viking Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
258.29
Quantity 83,324
Value US$829,571
Transaction date
Sale
Price
137.17
Quantity 59,086 +1.8%
Value US$1,842,039
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-08 2024-11-08
PrS Proposed sale
83,324
258.29
US$829,571 		83,324 258.29 US$829,571
2024-11-08 2024-11-08
S Sale
59,086 +1.8%
137.17
US$1,842,039 		59,086 +1.8% 137.17 US$1,842,039
2023-05-18 2023-05-16
PlS Planned sale
25,983 -47.7%
439.74
US$3,411,477 		25,983 -47.7% 439.74 US$3,411,477
2023-05-16 2023-05-16
PrS Proposed sale
16,000
24.00
US$384,000 		16,000 24.00 US$384,000
2023-04-24 2023-04-24
PrS Proposed sale
16,000
22.00
US$352,060 		16,000 22.00 US$352,060
2023-04-24 2023-04-24
PlS Planned sale
16,000 -25.0%
22.00
US$352,061 		16,000 -25.0% 22.00 US$352,061
2023-04-18 2023-04-17
PlS Planned sale
20,786 -30.2%
20.00
US$415,720 		20,786 -30.2% 20.00 US$415,720
2023-04-17 2023-04-17
PrS Proposed sale
20,785
20.00
US$415,720 		20,785 20.00 US$415,720
2018-02-27 2018-02-27
B Purchase
2,940
68.00
US$199,920 		2,940 68.00 US$199,920